SonoMotion is developing non-invasive solutions for kidney stone disease with two breakthrough products. Founded by Doug Corl and Oren Levy in 2014, Sonomotion is backed by investors that include Advanced MedTech Holdings (AMTH), Bioventures Investors, and MedVenture Partners and is headquartered in South San Francisco.